Indacaterol (Indacaterol)
Overview of Indacaterol
Indacaterol maleate is a selective beta2-adrenergic agonist. Its chemical name is (R)-5-[2-(5,6-Diethylindan-2-ylamino)-1-hydroxyethyl]-8- hydroxy-1H-quinolin-2-one maleate.it is indicated for long term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
Indication of Indacaterol
Indacaterol is primarily indicated in conditions like Chronic bronchitis, Chronic obstructive pulmonary disease, Emphysema.
Contraindication of Indacaterol
No data regarding the contra indications of Indacaterol is available.
Side Effects of Indacaterol
The symptomatic adverse reactions produced by Indacaterol are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Nausea, Cough, Nasopharyngitis, oropharyngeal pain.
Precautions of Indacaterol
Do not initiate in acutely deteriorating COPD patients. Do not use for relief of acute symptoms. Concomitant short-acting beta2- agonists can be used as needed for acute relief. Do not exceed the recommended dose. Excessive use or use inconjunction with other medications containing LABA can result in clinically significant cardiovascular effects and may be fatal. Immediate hypersensitivity reactions may occur. Discontinue immediately. Life-threatening paradoxical bronchospasm can occur. Discontinue immediately. Use with caution in patients with cardiovascular or convulsive disorders, thyrotoxicosis or sensitivity to sympathomimetic drugs.